Ahead of the eyeforpharma Awards we spoke to judge Jennifer Wong – AstraZeneca’s senior director, RWE strategy & alliances, global medical affairs – about why collaboration and RWE
Ahead of the eyeforpharma Awards shortlist announcement this week, we spoke to judge and commercial insights executive Peter Barschdorff about how data and insights are changing pharma
Richard Staines discusses what has become one of the worst deals in pharma’s history – AbbVie’s purchase of Stemcentrx and its lung cancer drug Rova-T.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
